Skip to main content
. Author manuscript; available in PMC: 2015 May 1.
Published in final edited form as: Gastroenterology. 2014 Jan 8;146(5):1256–1265.e1. doi: 10.1053/j.gastro.2014.01.005

Table 6.

Competing Risk Model Evaluating Risk of Pre-transplantation Death on the Waitlist or Within 90 Days of De-Listing of HPS vs Non-HPS Waitlist Candidatesa

Variable Multivariable SHR (95% CI) P valueb
HPS 0.41 (0.31–0.55) <.001
Age at listingc 1.27 (1.23–1.31) <.001
Male sex 0.85 (0.79–0.92) <.001
Race/ethnicity <.001
 White 1
 Black 0.86 (0.78–0.95)
 Hispanic 1.10 (0.98–1.25)
 Asian 1.05 (0.97–1.12)
 Other 1.12 (0.92–1.35)
Initial laboratory MELD scored 1.03 (1.02–1.03) <.001
Primary diagnosis <.001
 Hepatitis C 1
 Alcohol 0.80 (0.77–0.83)
 Hepatitis B 0.82 (0.74–0.91)
 NASH/cryptogenic 0.80 (0.74–0.87)
 Cholestatic 0.74 (0.67–0.82)
 Autoimmune 0.81 (0.75–0.87)
 Other 1.00 (0.89–1.12)
Ascites before listing 1.23 (1.12–1.34) <.001
Blood type
 O 1 <.001
 A 0.97 (0.92–1.02)
 B 0.79 (0.73–0.86)
 AB 0.49 (0.44–0.55)
Initial serum albumin 0.74 (0.69–0.79) <.001

NASH, nonalcoholic steatohepatitis.

a

Competing risk Cox regression model, treating transplantation as a competing risk. Results reported as sub-hazard ratios (SHRs) instead of hazard ratios.

b

P value for multivariable hazard ratio.

c

Hazard for every increase in 10 years at listing.

d

SHR represents increased risk for every 1 MELD point.